Genetic mapping studies of familial juvenile hyperuricemic nephropathy on chromosome 16p11-p13

Journal of Clinical Endocrinology and Metabolism

Volumn 88, Issue 1, 2003, Pages 464-470

  Stacey, Joanna M ^a   Turner, Jeremy J O ^a   Harding, Brian ^a   Andrew Nesbit, M ^a   Kotanko, Peter ^b   Lhotta, Karl ^c   Puig, Juan G ^d   Torres, Rosa J ^d   Thakker, Rajesh V ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

^d General University Hospital   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

URATE;

ARTICLE; AUTOSOMAL DOMINANT DISORDER; CHROMOSOME 16P; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL JUVENILE HYPERURICEMIC NEPHROPATHY; FAMILY; GENE CONTROL; GENE LOCATION; GENE LOCUS; GENE MAPPING; GENETIC HETEROGENEITY; GENETIC LINKAGE; HAPLOTYPE; HUMAN; KIDNEY DISEASE; LINKAGE ANALYSIS; METABOLISM; PRIORITY JOURNAL; TELOMERE;

CHILD; CHROMOSOME MAPPING; CHROMOSOME SEGREGATION; CHROMOSOMES, HUMAN, PAIR 16; FEMALE; GENETIC HETEROGENEITY; HUMANS; HYPERURICEMIA; KIDNEY; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; LINKAGE (GENETICS); MALE; PEDIGREE; URIC ACID;

EID: 0037244798     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2002-021268     Document Type: Article

References (29)

1. Duncan H, Dixon ACJ 1960 Gout, familial hyperuricaemia and renal disease. Q J Med 29:127-136
2. Calabrese G, Simmonds HA, Cameron JS, Davies PM 1990 Precocious familial gout with reduced fractional urate clearance and normal purine enzymes. Q J Med 75:441-450
3. Moro F, Ogg CS, Simmonds HA, Cameron JS, Chantler C, McBride MB, Duley JA, Davies PM 1991 Familial juvenile gouty nephropathy with renal urate hypoexcretion preceding renal disease. Clin Nephrol 35:263-269
4. Moro F, Simmonds HA, Cameron JS, Ogg CS, Williams GD, McBride MB, Davis PM 1991 Does allopurinol affect the progression of familial juvenile gouty nephropathy? Adv Exp Med Biol 199-202
5. McBride MB, Simmonds HA, Ogg CS, Cameron JS, Rigden S, Rees L, Van 't Hoff W, Moro F, Raman GV 1998 Efficacy of allopurinol in ameliorating the progressive renal disease in familial juvenile hyperuricaemic nephropathy (FJHN). A six-year update. Adv Exp Med Biol 431:7-11
6. Grahame R, Simmonds HA, McBride MB, Marsh FP 1998 How should we treat tophaceous gout in patients with allopurinol hypersensitivity? Adv Exp Med Biol 431:19-23
7. Puig JG, Miranda ME, Mateos FA, Picazo ML, Jimenez ML, Calvin TS, Gil AA 1993 Hereditary nephropathy associated with hyperuricemia and gout. Arch Intern Med 153:357-365
8. Dahan K, Fuchshuber A, Adamis S, Smaers M, Kroiss S, Loute G, Cosyns JP, Hildebrandt F, Verellen-Dumoulin C, Pirson Y 2001 Familial juvenile hyperuricemic nephropathy and autosomal dominant medullary cystic kidney disease type 2: two facets of the same disease? J Am Soc Nephrol 12:2348-2357
9. Kamatani N, Moritani M, Yamanaka H, Takeuchi F, Hosoya T, Itakura M 2000 Localization of a gene for familial juvenile hyperuricemic nephropathy causing underexcretion-type gout to 16p12 by genome-wide linkage analysis of a large family. Arthritis Rheum 43:925-929
10. Stiburkova B, Majewski J, Sebesta I, Zhang W, Ott J, Kmoch S 2000 Familial juvenile hyperuricemic nephropathy: localization of the gene on chromosome 16p11.2 and evidence for genetic heterogeneity. Am J Hum Genet 66:1989-1994
11. Scolari F, Ghiggeri GM, Casari G, Amoroso A, Puzzer D, Caridi GL, Valzorio B, Tardanico R, Vizzardi V, Savoldi S, Viola BF, Bossini N, Prati E, Gusmano R, Maiorca R 1998 Autosomal dominant medullary cystic disease: a disorder with variable clinical pictures and exclusion of linkage with the NPH1 locus. Nephrol Dial Transplant 13:2536-2546
12. Christodoulou K, Tsingis M, Stavrou C, Eleftheriou A, Papapavlou P, Patsalis PC, Ioannou P, Pierides A, Constantinou Deltas C 1998 Chromosome 1 localization of a gene for autosomal dominant medullary cystic kidney disease. Hum Mol Genet 7:905-911
13. Kotanko P, Gebetsroither E, Skrabal F 2002 Familial juvenile hyperuricaemic nephropathy in a Caucasian family associated with inborn malformations. Nephrol Dial Transplant 17:1333-1335
14. Lhotta K, Gruber J, Sgonc R, Fend F, Konig P 1998 Apoptosis of tubular epithelial cells in familial juvenile gouty nephropathy. Nephron 79:340-344
15. Miranda ME 1995 The influence of Allopurinol on renal deterioration in familial nephropathy associated with hyperuricaemia (FNAH). New York: Plenum Press; 61-64
16. Lloyd SE, Pannett AA, Dixon PH, Whyte MP, Thakker RV 1999 Localization of familial benign hypercalcemia, Oklahoma variant (FBHOk), to chromosome 19q13. Am J Hum Genet 64:189-195
17. Trump D, Whyte MP, Wooding C, Pang JT, Pearce SH, Kocher DB, Thakker RV 1995 Linkage studies in a kindred from Oklahoma, with familial benign (hypocalciuric) hypercalcaemia (FBH) and developmental elevations in serum parathyroid hormone levels, indicate a third locus for FBH. Hum Genet 96:183-187
18. Thakker RV, Davies KE, Whyte MP, Wooding C, O'Riordan JL 1990 Mapping the gene causing X-linked recessive idiopathic hypoparathyroidism to Xq26-Xq27 by linkage studies. J Clin Invest 86:40-45
19. Ott J 1976 A computer program for linkage analysis of general human pedigrees. Am J Hum Genet 28:528-529
20. Nathanson KL, Shugart YY, Omaruddin R, Szabo C, Goldgar D, Rebbeck TR, Weber BL 2002 CGH-targeted linkage analysis reveals a possible BRCA1 modifier locus on chromosome 5q. Hum Mol Genet 11:1327-1332
21. Stavrou C, Pierides A, Zouvani I, Kyriacou K, Antignac C, Neophytou P, Christodoulou K, Deltas CC 1998 Medullary cystic kidney disease with hyperuricemia and gout in a large Cypriot family: no allelism with nephronophthisis type 1. Am J Med Genet 77:149-154
22. Burke JR, Inglis JA, Craswell PW, Mitchell KR, Emmerson BT 1982 Juvenile nephronophthisis and medullary cystic disease-the same disease (report of a large family with medullary cystic disease associated with gout and epilepsy). Clin Nephrol 18:1-8
23. Thompson GR, Weiss JJ, Goldman RT, Rigg GA 1978 Familial occurrence of hyperuricemia, gout, and medullary cystic disease. Arch Intern Med 138:1614-1617
24. Loftus BJ, Kim UJ, Sneddon VP, Kalush F, Brandon R, Fuhrmann J, Mason T, Crosby ML, Barnstead M, Cronin L, Deslattes Mays A, Cao Y, Xu RX, Kang HL, Mitchell S, Eichler EE, Harris PC, Venter JC, Adams MD 1999 Genome duplications and other features in 12 Mb of DNA sequence from human chromosome 16p and 16q. Genomics 60:295-308
25. Hansson JH, Nelson-Williams C, Suzuki H, Schild L, Shimkets R, Lu Y, Canessa C, Iwasaki T, Rossier B, Lifton RP 1995 Hypertension caused by a truncated epithelial sodium channel γ subunit: genetic heterogeneity of Liddle syndrome. Nat Genet 11:76-82
26. Hansson JH, Schild L, Lu Y, Wilson TA, Gautschi I, Shimkets R, Nelson-Williams C, Rossier BC, Lifton RP 1995 A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity. Proc Natl Acad Sci USA 92:11495-11499
27. Caraballo R, Pavek S, Lemainque A, Gastaldi M, Echenne B, Motte J, Genton P, Cersosimo R, Humbertclaude V, Fejerman N, Monaco AP, Lathrop MG, Rochette J, Szepetowski P 2001 Linkage of benign familial infantile convulsions to chromosome 16p12-q12 suggests allelism to the infantile convulsions and choreoathetosis syndrome. Am J Hum Genet 68:788-794
28. Hateboer N, Gumbs C, Teare MD, Coles GA, Griffiths D, Ravine D, Futreal PA, Rahman N 2001 Confirmation of a gene locus for medullary cystic kidney disease (MCKD2) on chromosome 16p12. Kidney Int 60:1233-1239
29. Scolari F, Puzzer D, Amoroso A, Caridi G, Ghiggeri GM, Maiorca R, Aridon P, De Fusco M, Ballabio A, Casari G 1999 Identification of a new locus for medullary cystic disease, on chromosome 16p12. Am J Hum Genet 64:1655-1660